Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Breast cancer recurrence and metastases analyzed with FDG-PET
June 2nd, 2005
Researchers critiqued the performance of F-18-2-deoxy-2-fluoro-D-glucose-positron emission tomography (FDG-PET) in evaluating breast cancer recurrence. Researchers in the United States conducted a study "to evaluate the diagnostic performance of FDG-PET in the evaluation of breast cancer recurrence and metastases." "Articles published in medical journals during January 1995-June 2004 were identified by a systematic Medline search, supplemented by a manual search of the references listed in original and review articles. Studies that evaluated FDG-PET with a dedicated camera for the diagnosis of breast cancer recurrence or metastases, and reporting...
Source: Women's Health Weekly (2005-06-02)
|
